Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa M Parker

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Obesity (Silver Spring, Md.)|March 29, 2023
An electronic medical record (EMR) prompt improves screening rates for metabolic conditions among children with obesityNolan E Lee, Melissa M Parker, Josephine Q Concepcion
Diabetes Technology & Therapeutics|April 16, 2025
Dysglycemic Events after Initiation of Intermittently Scanned Continuous Glucose Monitoring in Patients with Insulin-Treated Type 2 DiabetesLisa K Gilliam, Melissa M Parker, Andrew J Karter
Journal of the American Medical Informatics Association : JAMIA|June 17, 2015
An algorithm to identify medication nonpersistence using electronic pharmacy databasesMelissa M Parker, Howard H Moffet, Alyce Adams, et al.
Diabetes Technology & Therapeutics|August 3, 2023
Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1cAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
JAMA Internal Medicine|January 24, 2017
Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With DiabetesAlicia Fernández, Judy Quan, Howard Moffet, et al.
JAMA|June 2, 2021
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
Diabetes Technology & Therapeutics|February 1, 2022
Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 DiabetesAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
Diabetes Care|September 19, 2014
Incidence of remission in adults with type 2 diabetes: the diabetes & aging studyAndrew J Karter, Shantanu Nundy, Melissa M Parker, et al.
The Permanente Journal|May 4, 2019
Clinical Response to Real-Time Patient-Reported Diabetic Peripheral Neuropathy SymptomsSomalee Banerjee, Eileen Kim, Melissa M Parker, et al.
Diabetes Technology & Therapeutics|January 26, 2024
Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive ValueLisa K Gilliam, Melissa M Parker, Howard H Moffet, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Obesity (Silver Spring, Md.)|March 29, 2023
An electronic medical record (EMR) prompt improves screening rates for metabolic conditions among children with obesityNolan E Lee, Melissa M Parker, Josephine Q Concepcion
Diabetes Technology & Therapeutics|April 16, 2025
Dysglycemic Events after Initiation of Intermittently Scanned Continuous Glucose Monitoring in Patients with Insulin-Treated Type 2 DiabetesLisa K Gilliam, Melissa M Parker, Andrew J Karter
Journal of the American Medical Informatics Association : JAMIA|June 17, 2015
An algorithm to identify medication nonpersistence using electronic pharmacy databasesMelissa M Parker, Howard H Moffet, Alyce Adams, et al.
Diabetes Technology & Therapeutics|August 3, 2023
Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1cAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
JAMA Internal Medicine|January 24, 2017
Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With DiabetesAlicia Fernández, Judy Quan, Howard Moffet, et al.
JAMA|June 2, 2021
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
Diabetes Technology & Therapeutics|February 1, 2022
Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 DiabetesAndrew J Karter, Melissa M Parker, Howard H Moffet, et al.
Diabetes Care|September 19, 2014
Incidence of remission in adults with type 2 diabetes: the diabetes & aging studyAndrew J Karter, Shantanu Nundy, Melissa M Parker, et al.
The Permanente Journal|May 4, 2019
Clinical Response to Real-Time Patient-Reported Diabetic Peripheral Neuropathy SymptomsSomalee Banerjee, Eileen Kim, Melissa M Parker, et al.
Diabetes Technology & Therapeutics|January 26, 2024
Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive ValueLisa K Gilliam, Melissa M Parker, Howard H Moffet, et al.
Pageof 6